Clinical TrialsSearch results
Number of results: 67226
Not yet recruiting
- PAH Physician Survey
- Pulmonary arterial hypertension
- Arai Yoko
- 2024-06-04
Not yet recruiting
- Study on the variation of urinary erythropoietin
- Not applicable
- Fukushima Medical University
- 2024-06-04
Not yet recruiting
- The Effectiveness of Mobile Application for Preventing Antenatal Depression Among Pregnant Women
- pregnant women
- Osaka Medical and Pharmaceutical University
- 2024-06-04
Recruiting
- Epigenetic genetic analysis of lens epithelium and retinal proliferative membrane in ocular diseases.
- Cataract, ischemic retinal disease (including diabetic retinopathy, retinal vein occlusion, retinopathy of prematurity)
- University of Fukui
- 2024-06-04
Recruiting
- General Drug Use-Results Survey of COMLEX OTIC SOLUTION 1.5%
- Otitis externa, Chronic otitis media, and Acute otitis media
- CEOLIA Pharma.Co.Ltd Pharmacovigilance Office
- 2024-06-04
Recruiting
- JBCRG-M10 (INDUCE trial)
- PD-L1-positive, hormone receptor-negative, HER2-negative inoperable or recurrent breast cancer
- Ozaki Yukinori
- 2024-06-04
Recruiting
- Stent-less Treatment Strategy for acute coronary syndrome
- Acute coronary syndrome
- Hibi Kiyoshi
- 2024-06-04
Not yet recruiting
- A Phase 3 Study to Evaluate MK-2870 in Advanced/Metastatic Gastroesophageal Adenocarcinoma
- Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, and Esophageal Adenocarcinoma
- Koh Yasuhiro
- 2024-06-03
Not yet recruiting
- A Study on the Effect of Plant-Derived Products on Immune-related indicators
- No
- KSO Corporation
- 2024-06-03
Not yet recruiting
- Beamion BCGC-1: A Phase Ib and Phase II trial of zongertinib in combination with intravenous trastuzumab deruxtecan (T-DXd) or in combination with intravenous trastuzumab emtansine (T-DM1) for treatment of patients with advanced HER2+ mBC and mGEAC
- Advanced HER2+ mBC and mGEAC
- Sila Aykut Yazgili
- 2024-06-03